ID   CD36_HUMAN              Reviewed;         472 AA.
AC   P16671; Q13966; Q16093; Q8TCV7; Q9BPZ8; Q9BQC2; Q9BZM8; Q9BZN3;
AC   Q9BZN4; Q9BZN5;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   21-MAR-2012, entry version 136.
DE   RecName: Full=Platelet glycoprotein 4;
DE   AltName: Full=Fatty acid translocase;
DE            Short=FAT;
DE   AltName: Full=Glycoprotein IIIb;
DE            Short=GPIIIB;
DE   AltName: Full=Leukocyte differentiation antigen CD36;
DE   AltName: Full=PAS IV;
DE   AltName: Full=PAS-4;
DE   AltName: Full=Platelet collagen receptor;
DE   AltName: Full=Platelet glycoprotein IV;
DE            Short=GPIV;
DE   AltName: Full=Thrombospondin receptor;
DE   AltName: CD_antigen=CD36;
GN   Name=CD36; Synonyms=GP3B, GP4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   MEDLINE=89324065; PubMed=2473841; DOI=10.1016/0092-8674(89)90406-6;
RA   Oquendo P., Hundt E., Lawler J., Seed B.;
RT   "CD36 directly mediates cytoadherence of Plasmodium falciparum
RT   parasitized erythrocytes.";
RL   Cell 58:95-101(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Sugimoto Y., Tsuruo T.;
RL   Submitted (AUG-1992) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=94040811; PubMed=7693552; DOI=10.1016/0378-1119(93)90639-K;
RA   Taylor K.T., Tang Y., Sobieski D.A., Lipsky R.H.;
RT   "Characterization of two alternatively spliced 5'-untranslated exons
RT   of the human CD36 gene in different cell types.";
RL   Gene 133:205-212(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Platelet;
RX   MEDLINE=94082337; PubMed=7505064;
RA   Wyler B., Daviet L., Bortkiewicz H., Bordet J.C., McGregor J.L.;
RT   "Cloning of the cDNA encoding human platelet CD36: comparison to PCR
RT   amplified fragments of monocyte, endothelial and HEL cells.";
RL   Thromb. Haemost. 70:500-505(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=94308159; PubMed=7518447;
RA   Armesilla A.L., Vega M.A.;
RT   "Structural organization of the gene for human CD36 glycoprotein.";
RL   J. Biol. Chem. 269:18985-18991(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-37, AND GLYCOSYLATION.
RC   TISSUE=Platelet;
RX   MEDLINE=89214205; PubMed=2468669;
RA   Tandon N.N., Lipsky R.H., Burgess W.H., Jamieson G.A.;
RT   "Isolation and characterization of platelet glycoprotein IV (CD36).";
RL   J. Biol. Chem. 264:7570-7575(1989).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-203; 274-375 AND 419-472, AND
RP   VARIANTS LYS-123; ALA-174; ASN-232 INS AND THR-271.
RX   MEDLINE=21523008; PubMed=11668637; DOI=10.1002/humu.1215;
RA   Gelhaus A., Scheding A., Browne E., Burchard G.D., Horstmann R.D.;
RT   "Variability of the CD36 gene in West Africa.";
RL   Hum. Mutat. 18:444-450(2001).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 144-203.
RX   MEDLINE=94063924; PubMed=7503937; DOI=10.1006/geno.1993.1401;
RA   Fernandez-Ruiz E., Armesilla A.L., Sanchez-Madrid F., Vega M.A.;
RT   "Gene encoding the collagen type I and thrombospondin receptor CD36 is
RT   located on chromosome 7q11.2.";
RL   Genomics 17:759-761(1993).
RN   [11]
RP   PROTEIN SEQUENCE OF 261-273 AND 369-385.
RC   TISSUE=Adipocyte;
RX   PubMed=15242332; DOI=10.1042/BJ20040647;
RA   Aboulaich N., Vainonen J.P., Stralfors P., Vener A.V.;
RT   "Vectorial proteomics reveal targeting, phosphorylation and specific
RT   fragmentation of polymerase I and transcript release factor (PTRF) at
RT   the surface of caveolae in human adipocytes.";
RL   Biochem. J. 383:237-248(2004).
RN   [12]
RP   INTERACTION WITH THBS1 AND THBS2.
RX   PubMed=1371676; DOI=10.1016/0006-291X(92)91860-S;
RA   Asch A.S., Silbiger S., Heimer E., Nachman R.L.;
RT   "Thrombospondin sequence motif (CSVTCG) is responsible for CD36
RT   binding.";
RL   Biochem. Biophys. Res. Commun. 182:1208-1217(1992).
RN   [13]
RP   PALMITOYLATION AT CYS-3; CYS-7; CYS-464 AND CYS-466.
RX   MEDLINE=96394284; PubMed=8798390; DOI=10.1074/jbc.271.37.22315;
RA   Tao N., Wagner S.J., Lublin D.M.;
RT   "CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails.";
RL   J. Biol. Chem. 271:22315-22320(1996).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-417, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=16263699; DOI=10.1074/mcp.M500324-MCP200;
RA   Lewandrowski U., Moebius J., Walter U., Sickmann A.;
RT   "Elucidation of N-glycosylation sites on human platelet proteins: a
RT   glycoproteomic approach.";
RL   Mol. Cell. Proteomics 5:226-233(2006).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-321, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Milk;
RX   PubMed=18780401; DOI=10.1002/pmic.200701057;
RA   Picariello G., Ferranti P., Mamone G., Roepstorff P., Addeo F.;
RT   "Identification of N-linked glycoproteins in human milk by hydrophilic
RT   interaction liquid chromatography and mass spectrometry.";
RL   Proteomics 8:3833-3847(2008).
RN   [16]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-205 AND ASN-417, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [17]
RP   VARIANT PG4D SER-90.
RX   MEDLINE=95189997; PubMed=7533783; DOI=10.1172/JCI117749;
RA   Kashiwagi H., Tomiyama Y., Honda S., Kosugi S., Shiraga M., Nagao N.,
RA   Sekiguchi S., Kanayama Y., Kurata Y., Matsuzawa Y.;
RT   "Molecular basis of CD36 deficiency. Evidence that a 478C-->T
RT   substitution (proline90-->serine) in CD36 cDNA accounts for CD36
RT   deficiency.";
RL   J. Clin. Invest. 95:1040-1046(1995).
RN   [18]
RP   VARIANT PHE-154.
RX   MEDLINE=99318093; PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [19]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [20]
RP   ROLE IN MALARIA INFECTION.
RX   MEDLINE=20346487; PubMed=10890433; DOI=10.1038/35016636;
RA   Aitman T.J., Cooper L.D., Norsworthy P.J., Wahid F.N., Gray J.K.,
RA   Curtis B.R., McKeigue P.M., Kwiatkowski D., Greenwood B.M., Snow R.W.,
RA   Hill A.V., Scott J.;
RT   "Malaria susceptibility and CD36 mutation.";
RL   Nature 405:1015-1016(2000).
RN   [21]
RP   VARIANTS PG4D SER-90; LEU-254 AND LEU-413.
RX   MEDLINE=21947857; PubMed=11950861; DOI=10.1136/jmg.39.4.286;
RA   Hanawa H., Watanabe K., Nakamura T., Ogawa Y., Toba K., Fuse I.,
RA   Kodama M., Kato K., Fuse K., Aizawa Y.;
RT   "Identification of cryptic splice site, exon skipping, and novel point
RT   mutations in type I CD36 deficiency.";
RL   J. Med. Genet. 39:286-291(2002).
RN   [22]
RP   VARIANT LEU-127, AND ROLE IN MALARIA INFECTION.
RX   MEDLINE=22428291; PubMed=12506336; DOI=10.1086/346091;
RA   Omi K., Ohashi J., Patarapotikul J., Hananantachai H., Naka I.,
RA   Looareesuwan S., Tokunaga K.;
RT   "CD36 polymorphism is associated with protection from cerebral
RT   malaria.";
RL   Am. J. Hum. Genet. 72:364-374(2003).
RN   [23]
RP   INVOLVEMENT IN CHDS7.
RX   PubMed=15282206; DOI=10.1093/hmg/ddh233;
RA   Ma X., Bacci S., Mlynarski W., Gottardo L., Soccio T., Menzaghi C.,
RA   Iori E., Lager R.A., Shroff A.R., Gervino E.V., Nesto R.W.,
RA   Johnstone M.T., Abumrad N.A., Avogaro A., Trischitta V., Doria A.;
RT   "A common haplotype at the CD36 locus is associated with high free
RT   fatty acid levels and increased cardiovascular risk in Caucasians.";
RL   Hum. Mol. Genet. 13:2197-2205(2004).
RN   [24]
RP   ERRATUM.
RA   Ma X., Bacci S., Mlynarski W., Gottardo L., Soccio T., Menzaghi C.,
RA   Iori E., Lager R.A., Shroff A.R., Gervino E.V., Nesto R.W.,
RA   Johnstone M.T., Abumrad N.A., Avogaro A., Trischitta V., Doria A.;
RL   Hum. Mol. Genet. 14:3973-3973(2005).
CC   -!- FUNCTION: Seems to have numerous potential physiological
CC       functions. Binds to collagen, thrombospondin, anionic
CC       phospholipids and oxidized LDL. May function as a cell adhesion
CC       molecule. Directly mediates cytoadherence of Plasmodium falciparum
CC       parasitized erythrocytes. Binds long chain fatty acids and may
CC       function in the transport and/or as a regulator of fatty acid
CC       transport. Receptor for thombospondins, THBS1 AND THBS2, mediating
CC       their antiangiogenic effects.
CC   -!- SUBUNIT: Interacts with THBS1 and THBS2; the interactions mediate
CC       the THBS antiangiogenic activity.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- PTM: N-glycosylated and O-glycosylated with a ratio of 2:1.
CC   -!- POLYMORPHISM: Genetic variations in CD36 are involved in
CC       susceptibility to malaria and influence the severity and outcome
CC       of malaria infection [MIM:611162].
CC   -!- DISEASE: Defects in CD36 are the cause of platelet glycoprotein IV
CC       deficiency (PG4D)[MIM:608404]; also known as CD36 deficiency.
CC       Platelet glycoprotein IV deficiency can be divided into 2
CC       subgroups. The type I phenotype is characterized by platelets and
CC       monocytes/macrophages exhibiting complete CD36 deficiency. The
CC       type II phenotype lacks the surface expression of CD36 in
CC       platelets, but expression in monocytes/macrophages is near normal.
CC   -!- DISEASE: Genetic variations in CD36 are associated with
CC       susceptibility to coronary heart disease type 7 (CHDS7)
CC       [MIM:610938].
CC   -!- SIMILARITY: Belongs to the CD36 family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAM14636.2; Type=Frameshift; Positions=53;
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CD36 entry;
CC       URL="http://en.wikipedia.org/wiki/CD36";
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/CD36";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/cd36/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24795; AAA35534.1; -; mRNA.
DR   EMBL; M98398; AAA58412.1; -; mRNA.
DR   EMBL; M98399; AAA58413.1; -; mRNA.
DR   EMBL; L06850; AAA16068.1; -; mRNA.
DR   EMBL; S67532; AAD13993.1; -; mRNA.
DR   EMBL; Z32770; CAA83662.1; -; Genomic_DNA.
DR   EMBL; Z32754; CAA83662.1; JOINED; Genomic_DNA.
DR   EMBL; Z32755; CAA83662.1; JOINED; Genomic_DNA.
DR   EMBL; Z32756; CAA83662.1; JOINED; Genomic_DNA.
DR   EMBL; Z32757; CAA83662.1; JOINED; Genomic_DNA.
DR   EMBL; Z32758; CAA83662.1; JOINED; Genomic_DNA.
DR   EMBL; Z32759; CAA83662.1; JOINED; Genomic_DNA.
DR   EMBL; Z32760; CAA83662.1; JOINED; Genomic_DNA.
DR   EMBL; Z32761; CAA83662.1; JOINED; Genomic_DNA.
DR   EMBL; Z32762; CAA83662.1; JOINED; Genomic_DNA.
DR   EMBL; Z32763; CAA83662.1; JOINED; Genomic_DNA.
DR   EMBL; Z32764; CAA83662.1; JOINED; Genomic_DNA.
DR   EMBL; AY095373; AAM14636.2; ALT_FRAME; Genomic_DNA.
DR   EMBL; BC008406; AAH08406.1; -; mRNA.
DR   EMBL; AF300626; AAG60625.1; -; Genomic_DNA.
DR   EMBL; AF300627; AAG60626.1; -; Genomic_DNA.
DR   EMBL; AF300628; AAG60627.1; -; Genomic_DNA.
DR   EMBL; AF300633; AAG60632.1; -; Genomic_DNA.
DR   EMBL; AF300634; AAG60633.1; -; Genomic_DNA.
DR   EMBL; AF300635; AAG60634.1; -; Genomic_DNA.
DR   EMBL; AF300639; AAG60638.1; -; Genomic_DNA.
DR   EMBL; AF300640; AAG60639.1; -; Genomic_DNA.
DR   EMBL; S67044; AAB28992.1; -; mRNA.
DR   EMBL; Z22924; CAA80504.1; -; Genomic_DNA.
DR   IPI; IPI00418495; -.
DR   PIR; A54870; A54870.
DR   RefSeq; NP_000063.2; NM_000072.3.
DR   RefSeq; NP_001001547.1; NM_001001547.2.
DR   RefSeq; NP_001001548.1; NM_001001548.2.
DR   RefSeq; NP_001120915.1; NM_001127443.1.
DR   RefSeq; NP_001120916.1; NM_001127444.1.
DR   UniGene; Hs.120949; -.
DR   ProteinModelPortal; P16671; -.
DR   IntAct; P16671; 7.
DR   STRING; P16671; -.
DR   PhosphoSite; P16671; -.
DR   DMDM; 115982; -.
DR   PRIDE; P16671; -.
DR   DNASU; 948; -.
DR   Ensembl; ENST00000309881; ENSP00000308165; ENSG00000135218.
DR   Ensembl; ENST00000394788; ENSP00000378268; ENSG00000135218.
DR   Ensembl; ENST00000432207; ENSP00000411411; ENSG00000135218.
DR   Ensembl; ENST00000433696; ENSP00000401863; ENSG00000135218.
DR   Ensembl; ENST00000435819; ENSP00000399421; ENSG00000135218.
DR   Ensembl; ENST00000447544; ENSP00000415743; ENSG00000135218.
DR   GeneID; 948; -.
DR   KEGG; hsa:948; -.
DR   UCSC; uc003uhc.1; human.
DR   CTD; 948; -.
DR   GeneCards; GC07P080069; -.
DR   H-InvDB; HIX0006805; -.
DR   HGNC; HGNC:1663; CD36.
DR   HPA; CAB025866; -.
DR   HPA; HPA002018; -.
DR   MIM; 173510; gene.
DR   MIM; 248310; phenotype.
DR   MIM; 608404; phenotype.
DR   MIM; 610938; phenotype.
DR   MIM; 611162; phenotype.
DR   neXtProt; NX_P16671; -.
DR   eggNOG; NOG257244; -.
DR   GeneTree; ENSGT00530000062927; -.
DR   HOVERGEN; HBG002754; -.
DR   InParanoid; P16671; -.
DR   KO; K06259; -.
DR   OMA; FLSLVPY; -.
DR   OrthoDB; EOG4KWJT5; -.
DR   PhylomeDB; P16671; -.
DR   Reactome; REACT_111045; Developmental Biology.
DR   Reactome; REACT_111217; Metabolism.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Immune System.
DR   NextBio; 3938; -.
DR   ArrayExpress; P16671; -.
DR   Bgee; P16671; -.
DR   Genevestigator; P16671; -.
DR   GermOnline; ENSG00000135218; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:BHF-UCL.
DR   GO; GO:0005624; C:membrane fraction; TAS:ProtInc.
DR   GO; GO:0045335; C:phagocytic vesicle; TAS:Reactome.
DR   GO; GO:0031092; C:platelet alpha granule membrane; TAS:Reactome.
DR   GO; GO:0008289; F:lipid binding; IDA:BHF-UCL.
DR   GO; GO:0030169; F:low-density lipoprotein particle binding; IDA:BHF-UCL.
DR   GO; GO:0005041; F:low-density lipoprotein receptor activity; IMP:BHF-UCL.
DR   GO; GO:0070053; F:thrombospondin receptor activity; ISS:BHF-UCL.
DR   GO; GO:0050431; F:transforming growth factor beta binding; ISS:BHF-UCL.
DR   GO; GO:0002479; P:antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; TAS:Reactome.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0044255; P:cellular lipid metabolic process; TAS:Reactome.
DR   GO; GO:0019934; P:cGMP-mediated signaling; IDA:BHF-UCL.
DR   GO; GO:0030301; P:cholesterol transport; ISS:BHF-UCL.
DR   GO; GO:0019915; P:lipid storage; IMP:BHF-UCL.
DR   GO; GO:0042953; P:lipoprotein transport; IMP:BHF-UCL.
DR   GO; GO:0034383; P:low-density lipoprotein particle clearance; IMP:BHF-UCL.
DR   GO; GO:0007263; P:nitric oxide mediated signal transduction; IDA:BHF-UCL.
DR   GO; GO:0015911; P:plasma membrane long-chain fatty acid transport; IDA:BHF-UCL.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0001954; P:positive regulation of cell-matrix adhesion; IDA:BHF-UCL.
DR   GO; GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   InterPro; IPR002159; CD36.
DR   InterPro; IPR005428; CD36_antigen.
DR   PANTHER; PTHR11923; CD36; 1.
DR   Pfam; PF01130; CD36; 1.
DR   PRINTS; PR01610; CD36ANTIGEN.
DR   PRINTS; PR01609; CD36FAMILY.
PE   1: Evidence at protein level;
KW   Cell adhesion; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Glycoprotein; Lipoprotein; Membrane;
KW   Palmitate; Polymorphism; Receptor; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    472       Platelet glycoprotein 4.
FT                                /FTId=PRO_0000144151.
FT   TOPO_DOM      2      7       Cytoplasmic (Potential).
FT   TRANSMEM      8     29       Helical; (Potential).
FT   TOPO_DOM     30    439       Extracellular (Potential).
FT   TRANSMEM    440    461       Helical; (Potential).
FT   TOPO_DOM    462    472       Cytoplasmic (Potential).
FT   REGION       93    120       Required for interaction with
FT                                thrombospondins, THBS1 and THBS2.
FT   LIPID         3      3       S-palmitoyl cysteine.
FT   LIPID         7      7       S-palmitoyl cysteine.
FT   LIPID       464    464       S-palmitoyl cysteine.
FT   LIPID       466    466       S-palmitoyl cysteine.
FT   CARBOHYD     79     79       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    102    102       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    134    134       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    163    163       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    205    205       N-linked (GlcNAc...).
FT   CARBOHYD    220    220       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    235    235       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    247    247       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    321    321       N-linked (GlcNAc...).
FT   CARBOHYD    417    417       N-linked (GlcNAc...).
FT   DISULFID    243    311       By similarity.
FT   DISULFID    272    333       By similarity.
FT   DISULFID    313    322       By similarity.
FT   VARIANT      90     90       P -> S (in PG4D; type I; degradation in
FT                                the cytoplasm due to defects in
FT                                maturation; dbSNP:rs3765187).
FT                                /FTId=VAR_017913.
FT   VARIANT     123    123       E -> K (in individuals from a malaria
FT                                endemic area in West Africa).
FT                                /FTId=VAR_017914.
FT   VARIANT     127    127       S -> L.
FT                                /FTId=VAR_019049.
FT   VARIANT     154    154       V -> F (in dbSNP:rs5957).
FT                                /FTId=VAR_013918.
FT   VARIANT     174    174       T -> A (in individuals from a malaria
FT                                endemic area in West Africa).
FT                                /FTId=VAR_017915.
FT   VARIANT     232    232       G -> GN (in individuals from a malaria
FT                                endemic area in West Africa).
FT                                /FTId=VAR_017916.
FT   VARIANT     254    254       F -> L (in PG4D; type I).
FT                                /FTId=VAR_017917.
FT   VARIANT     271    271       I -> T (in individuals from a malaria
FT                                endemic area in West Africa).
FT                                /FTId=VAR_017918.
FT   VARIANT     413    413       I -> L (in PG4D; type I).
FT                                /FTId=VAR_017919.
FT   CONFLICT     44     44       L -> R (in Ref. 4; AAD13993).
FT   CONFLICT    238    238       Y -> D (in Ref. 4; AAD13993).
FT   CONFLICT    374    374       E -> Q (in Ref. 3; AAA16068 and 11; AA
FT                                sequence).
SQ   SEQUENCE   472 AA;  53053 MW;  543E748259A094FA CRC64;
     MGCDRNCGLI AGAVIGAVLA VFGGILMPVG DLLIQKTIKK QVVLEEGTIA FKNWVKTGTE
     VYRQFWIFDV QNPQEVMMNS SNIQVKQRGP YTYRVRFLAK ENVTQDAEDN TVSFLQPNGA
     IFEPSLSVGT EADNFTVLNL AVAAASHIYQ NQFVQMILNS LINKSKSSMF QVRTLRELLW
     GYRDPFLSLV PYPVTTTVGL FYPYNNTADG VYKVFNGKDN ISKVAIIDTY KGKRNLSYWE
     SHCDMINGTD AASFPPFVEK SQVLQFFSSD ICRSIYAVFE SDVNLKGIPV YRFVLPSKAF
     ASPVENPDNY CFCTEKIISK NCTSYGVLDI SKCKEGRPVY ISLPHFLYAS PDVSEPIDGL
     NPNEEEHRTY LDIEPITGFT LQFAKRLQVN LLVKPSEKIQ VLKNLKRNYI VPILWLNETG
     TIGDEKANMF RSQVTGKINL LGLIEMILLS VGVVMFVAFM ISYCACRSKT IK
//
